Showing results (91-100 of 290) with videos related to

Sort By:
Pageof 29
The American Journal of Pathology|February 1, 1996
Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomasS Kauppila, J Saarela, F Stenbäck, et al.
British Journal of Cancer|January 1, 1996
Type I and type III collagen metabolites in adult osteosarcoma patientsT Wiklund, C Blomqvist, L Risteli, et al.
British Journal of Cancer|July 31, 1998
Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patientsT Saarto, C Blomqvist, J Risteli, et al.
British Journal of Cancer|January 1, 1997
Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancerT Kylmälä, T Taube, T L Tammela, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1993
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometryE F Eriksen, P Charles, F Melsen, et al.
Acta Endocrinologica|November 1, 1993
Possible variation in bone resorption during the normal menstrual cycleA Schlemmer, C Hassager, J Risteli, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 23, 1998
Comparison of three serum assays for bone collagen formation during postmenopausal estrogen-progestin therapyE Suvanto-Luukkonen, L Risteli, H Sundström, et al.
Calcified Tissue International|December 1, 1992
Assessment of bone formation by biochemical markers in metabolic bone disease: separation between osteoblastic activity at the cell and tissue levelP Charles, C Hasling, L Risteli, et al.
Cancer|February 15, 1995
Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasmsG G Zhu, L Risteli, M Mäkinen, et al.
British Journal of Rheumatology|November 1, 1994
Type I collagen degradation product in serum of patients with early rheumatoid arthritis: relationship to disease activity and radiological progression in a 3-year follow-upL Paimela, M Leirisalo-Repo, L Risteli, et al.
Pageof 29